These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26317211)

  • 21. Early activation of the interleukin-23-17 axis in a murine model of oropharyngeal candidiasis.
    Saunus JM; Wagner SA; Matias MA; Hu Y; Zaini ZM; Farah CS
    Mol Oral Microbiol; 2010 Oct; 25(5):343-56. PubMed ID: 20883223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An IL-17F.S65L Knock-In Mouse Reveals Similarities and Differences in IL-17F Function in Oral Candidiasis: A New Tool to Understand IL-17F.
    Zhou C; Monin L; Gordon R; Aggor FEY; Bechara R; Edwards TN; Kaplan DH; Gingras S; Gaffen SL
    J Immunol; 2020 Aug; 205(3):720-730. PubMed ID: 32601099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages.
    Gorgoni B; Maritano D; Marthyn P; Righi M; Poli V
    J Immunol; 2002 Apr; 168(8):4055-62. PubMed ID: 11937564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection.
    Mosci P; Gabrielli E; Luciano E; Perito S; Cassone A; Pericolini E; Vecchiarelli A
    Microbes Infect; 2014 Aug; 16(8):678-89. PubMed ID: 24980544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-36 and IL-1/IL-17 Drive Immunity to Oral Candidiasis via Parallel Mechanisms.
    Verma AH; Zafar H; Ponde NO; Hepworth OW; Sihra D; Aggor FEY; Ainscough JS; Ho J; Richardson JP; Coleman BM; Hube B; Stacey M; McGeachy MJ; Naglik JR; Gaffen SL; Moyes DL
    J Immunol; 2018 Jul; 201(2):627-634. PubMed ID: 29891557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections.
    Hernández-Santos N; Huppler AR; Peterson AC; Khader SA; McKenna KC; Gaffen SL
    Mucosal Immunol; 2013 Sep; 6(5):900-10. PubMed ID: 23250275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of
    Kirchner FR; Littringer K; Altmeier S; Tran VDT; Schönherr F; Lemberg C; Pagni M; Sanglard D; Joller N; LeibundGut-Landmann S
    Front Immunol; 2019; 10():330. PubMed ID: 30873177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting.
    Farah CS; Hu Y; Riminton S; Ashman RB
    Oral Microbiol Immunol; 2006 Aug; 21(4):252-5. PubMed ID: 16842510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal IgA Prevents Commensal
    Millet N; Solis NV; Swidergall M
    Front Immunol; 2020; 11():555363. PubMed ID: 33193324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological and epidemiological factors affecting candidiasis in HIV patients beginning antiretroviral therapy in an Asian clinic.
    Wulandari EAT; Saraswati H; Adawiyah R; Djauzi S; Wahyuningsih R; Price P
    Arch Oral Biol; 2017 Oct; 82():86-91. PubMed ID: 28622549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the Protective Role of IL-17 During Oropharyngeal Candidiasis.
    Saul-McBeth J; Conti HR
    Methods Mol Biol; 2022; 2542():361-373. PubMed ID: 36008677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic changes of Th1/Th2/Th17 cytokines and human beta defensin 2 in HIV-infected patients with oral candidiasis during the first year of highly active anti-retroviral therapy.
    Yong X; Liu Z; Jiang L; Tao R; Liu W; Zhang L; Peng Y; Lin X; Huang Y
    Arch Oral Biol; 2018 Aug; 92():62-67. PubMed ID: 29753928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis.
    Yadev NP; Murdoch C; Saville SP; Thornhill MH
    Microb Pathog; 2011 Jun; 50(6):278-85. PubMed ID: 21296654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of the beta-defensins hBD-2 and hBD-3 is differentially regulated by NF-kappaB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis.
    Steubesand N; Kiehne K; Brunke G; Pahl R; Reiss K; Herzig KH; Schubert S; Schreiber S; Fölsch UR; Rosenstiel P; Arlt A
    BMC Immunol; 2009 Jun; 10():36. PubMed ID: 19523197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CX3CR1 is dispensable for control of mucosal Candida albicans infections in mice and humans.
    Break TJ; Jaeger M; Solis NV; Filler SG; Rodriguez CA; Lim JK; Lee CC; Sobel JD; Netea MG; Lionakis MS
    Infect Immun; 2015 Mar; 83(3):958-65. PubMed ID: 25547797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model.
    Bichele R; Kärner J; Truusalu K; Smidt I; Mändar R; Conti HR; Gaffen SL; Peterson P; Laan M; Kisand K
    Eur J Immunol; 2018 Mar; 48(3):464-470. PubMed ID: 29150834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBPβ.
    Hernandez-Encinas E; Aguilar-Morante D; Morales-Garcia JA; Gine E; Sanz-SanCristobal M; Santos A; Perez-Castillo A
    J Neuroinflammation; 2016 Oct; 13(1):276. PubMed ID: 27769255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLR-2, IL-10 and IL-17-mediated immunity in experimental chemotherapy murine model of systemic candidiasis; cyclophosphamides' impact and roles.
    Dehghan P; Tolouie S; Baradaran B; Nami S; Morovati H
    Microb Pathog; 2018 Jun; 119():183-192. PubMed ID: 29673975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis.
    Leigh JE; Steele C; Wormley FL; Luo W; Clark RA; Gallaher W; Fidel PL
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):373-80. PubMed ID: 9833746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses.
    Bishu S; Su EW; Wilkerson ER; Reckley KA; Jones DM; McGeachy MJ; Gaffen SL; Levesque MC
    Arthritis Res Ther; 2014 Feb; 16(1):R50. PubMed ID: 24513269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.